160 related articles for article (PubMed ID: 25785188)
1. Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface.
Orro K; Smirnova O; Arshavskaja J; Salk K; Meikas A; Pihelgas S; Rumvolt R; Kingo K; Kazarjan A; Neuman T; Spee P
Biomark Res; 2014; 2():20. PubMed ID: 25785188
[TBL] [Abstract][Full Text] [Related]
2. Assessment of soluble skin surface protein levels for monitoring
Orro K; Salk K; Abram K; Arshavskaja J; Meikas A; Karelson M; Neuman T; Kingo K; Spee P
Front Med (Lausanne); 2023; 10():1072160. PubMed ID: 36936209
[TBL] [Abstract][Full Text] [Related]
3. Challenges in Noninvasive Skin Biomarker Measurements in Daily Practice: A Longitudinal Study on Skin Surface Protein Detection by the Transdermal Analysis Patch in Pediatric Psoriasis.
Schaap MJ; Bruins FM; van den Brink NJM; Orro K; Groenewoud HMM; de Jong EMGJ; van den Bogaard EH; Seyger MMB
Skin Pharmacol Physiol; 2022; 35(6):319-327. PubMed ID: 36202075
[TBL] [Abstract][Full Text] [Related]
4. Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy.
Orro K; Salk K; Merkulova A; Abram K; Karelson M; Traks T; Neuman T; Spee P; Kingo K
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003437
[TBL] [Abstract][Full Text] [Related]
5. Measurement of skin surface biomakers by Transdermal Analyses Patch following different in vivo models of irritation: a pilot study.
Falcone D; Spee P; Salk K; Peppelman M; van de Kerkhof PCM; van Erp PEJ
Skin Res Technol; 2017 Aug; 23(3):336-345. PubMed ID: 27800639
[TBL] [Abstract][Full Text] [Related]
6. Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis.
Schaap MJ; Bruins FM; He X; Orro K; Peppelman M; van Erp PEJ; de Jong EMGJ; Koenen HJPM; van den Bogaard EH; Seyger MMB
Skin Pharmacol Physiol; 2021; 34(5):271-280. PubMed ID: 34015784
[TBL] [Abstract][Full Text] [Related]
7. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases.
Terui T; Hirao T; Sato Y; Uesugi T; Honda M; Iguchi M; Matsumura N; Kudoh K; Aiba S; Tagami H
Exp Dermatol; 1998 Dec; 7(6):327-34. PubMed ID: 9858135
[TBL] [Abstract][Full Text] [Related]
8. A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation.
Perkins MA; Osterhues MA; Farage MA; Robinson MK
Skin Res Technol; 2001 Nov; 7(4):227-37. PubMed ID: 11737818
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
10. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption.
Janssens AS; Pavel S; Tensen CP; Teunissen MB; Out-Luiting JJ; Willemze R; de Gruijl FR
Exp Dermatol; 2009 Mar; 18(3):212-7. PubMed ID: 19046297
[TBL] [Abstract][Full Text] [Related]
11. Minimally-invasive Sampling of Interleukin-1α and Interleukin-1 Receptor Antagonist from the Skin: A Systematic Review of In vivo Studies in Humans.
Falcone D; Spee P; van de Kerkhof PCM; van Erp PEJ
Acta Derm Venereol; 2017 Oct; 97(9):1066-1073. PubMed ID: 28536733
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin.
Szegedi K; Lutter R; Res PC; Bos JD; Luiten RM; Kezic S; Middelkamp-Hup MA
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2136-44. PubMed ID: 25980674
[TBL] [Abstract][Full Text] [Related]
13. IL-1 Receptor Antagonist Reduced Chemical-Induced Keratinocyte Apoptosis through Antagonism to IL-1α/IL-1β.
Lee H; Cheong KA; Kim JY; Kim NH; Noh M; Lee AY
Biomol Ther (Seoul); 2018 Jul; 26(4):417-423. PubMed ID: 29310426
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
15. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD
J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297
[TBL] [Abstract][Full Text] [Related]
16. Artificial human skin: cytokine, prostaglandin, Hsp70 and histological responses to heat exposure.
Bowers W; Blaha M; Alkhyyat A; Sankovich J; Kohl J; Wong G; Patterson D
J Dermatol Sci; 1999 Jul; 20(3):172-82. PubMed ID: 10397388
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids.
Towbin H; Schmitz A; van Oostrum J; Seitz M; Dewald B; Zingel O; Motz J; Vosbeck K; Rordorf C
J Immunol Methods; 1994 Mar; 170(1):125-35. PubMed ID: 8157985
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture.
Mehta S; Akhtar S; Porter RM; Önnerfjord P; Bajpayee AG
Arthritis Res Ther; 2019 Nov; 21(1):238. PubMed ID: 31722745
[TBL] [Abstract][Full Text] [Related]
19. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J
Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
